To characterize the TME associated with tsMHC-II and tsMHC-I in breast cancer, tumors with high tsMHC-II expression demonstrated significantly greater infiltration of CD4 + and CD8 + T cells, along with closer spatial proximity of these T cells to tumor cells (Fig. 5E and 5F). The gene discussed is CD8A; the disease is breast carcinoma.